Last reviewed · How we verify
Pecan
At a glance
| Generic name | Pecan |
|---|---|
| Sponsor | Penn State University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Infancy to Toddlerhood: Early Nutrition & Tolerance (INTENT) (NA)
- Observational Pilot Study on Pomegranate Metabolism in Breastfeeding Women and Their Infants (NA)
- Cardiometabolic Effects of Including Pecans as a Snack in Dietary Patterns That Vary in Diet Quality: a Randomized, Controlled Feeding, Crossover Study (Phase 2)
- Measurement of PD-L1 Expression in Cancer to Monitor Treatment Response. (NA)
- Intermittent Fasting Monitoring for Human Optimization Utilizing Wearable Technology: an N-of-1 Prospective Study (NA)
- Dose Response Effects of Pecan Consumption (NA)
- Effect of Pecan Consumption on Aging (NA)
- Assessment of Systematic Health Properties of Pecan Nut Consumption: Gut, Vascular, Metabolic and Cognitive Outcomes (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |